Viewing Study NCT05976568


Ignite Creation Date: 2025-12-24 @ 5:34 PM
Ignite Modification Date: 2025-12-25 @ 3:50 PM
Study NCT ID: NCT05976568
Status: NOT_YET_RECRUITING
Last Update Posted: 2023-08-04
First Post: 2023-07-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of QL1706 in Combination With Bevacizumab and/or Chemotherapy as First-line Treatment in Patients With Advanced Hepatocellular Carcinoma
Sponsor: Qilu Pharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module